Active Ingredient(s): Atezolizumab
FDA Approved: * May 18, 2016
Pharm Company: * GENENTECH INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tecentriq Overview

Atezolizumab, sold under brand name Tecentriq, is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).[2] Contents 1 History 2 Medical uses 3 Adverse effects 4 Pharmacology 4.1 Mechanism of action 5 Drug cost controversy 6 Research 7 References 8 External links History In 2015, it was in clinical trials as an immunotherapy for several types of solid tumors.[2] It was under inves...

Read more Tecentriq Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Atezolizumab

Recent Tecentriq Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 1200mg/20ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tecentriq: (2 results)

Sorted by National Drug Code
  • 50242-917 Tecentriq 1200 mg/20ml Intravenous Injection, Solution by Genentech, Inc.
  • 50242-918 Tecentriq 840 mg/14ml Intravenous Injection, Solution by Genentech, Inc.

Other drugs which contain Atezolizumab or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 28 October 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA